Cannabinoid analgesia for medication abortion: A randomized controlled trial
Abortion
Awarded 2018
Complex Family Planning Fellowship Research
Katie Alton, MD
Oregon Health and Science University
$89,307

This study will be a randomized, double-blind, placebo controlled trial comparing pain levels in women undergoing medical abortion with one of two regimens: 1) ibuprofen 800mg and Sativex, and 2) ibuprofen 800mg and placebo at the time of misoprostol administration. Our primary objective will be to determine if a cannabinoid analgesic in addition to ibuprofen decreases maximum pain scores compared to ibuprofen and placebo when undergoing medical abortion. We plan to prospectively collect data via a text messaging system to evaluate pain scores, satisfaction, total analgesia use and adverse side effects. Results of this study will inform future providers who are counseling women undergoing medical abortion.

Skip to toolbar